The effect of time and temperature variables on routine coagulation tests

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood Coagulation and Fibrinolysis

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00001721-199809000-00002PMID 9818995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prothrombin time determination. The lack of need for a discard tube and 24-hour stability.

  1997cited by this paper
• The APTT Monitoring of Heparin - The ISTH/ICSH Collaborative Study

  1995cited by this paper
• Activation of factors XII and VII induced in citrated plasma in the presence of contact surface.

  1995cited by this paper
• Rapid preparation of plasma for 'Stat' coagulation testing.

  1994cited by this paper
• Establishing a Therapeutic Range for Heparin Therapy

  1993cited by this paper
• Monitoring Heparin Therapy by the Activated Partial Thromboplastin Time - The Effect of Pre-Analytical Conditions

  1987cited by this paper
• Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.

  1986cited by this paper
• The effect of platelet factor 4 (PF4) on assays of plasma heparin

  1984cited by this paper
• Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixture.

  1983cited by this paper
• Pre-instrumental variables in coagulation testing.

  1975cited by this paper

• Venepuncture: The Role of the Nurse in Ensuring Quality of the Preanalytical Stage and Cost-Effectiveness

  2026cites this paper
• Cold activation in PT-INR samples – Myth or reality in the modern laboratory?

  2025cites this paper
• Effects of storage time and temperature on coagulation factor and natural anticoagulant activities in healthy individuals

  2025cites this paper
• The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin—A Randomized, Controlled, Crossover Study

  2025cites this paper
• Consensus instability equations for routine coagulation tests

  2025cites this paper
• Measurement of heparin, direct oral anti‐coagulants and other non‐coumarin anti‐coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline

  2024cites this paper
• Stability of Hemostasis Parameters in Whole Blood, Plasma, and Frozen Plasma: Literature Review and Recommendations of the SFTH (French Society of Thrombosis and Haemostasis)

  2024cites this paper
• Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes

  2023cites this paper
• Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma

  2022cites this paper
• International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing

  2021cites this paper
• International Council for Standardisation in Haematology (ICSH) recommendations for collection of blood samples for coagulation testing

  2021cites this paper
• The stability of ‘add‐on’ coagulation assays in refrigerated citrated plasma stored on a packed cellular fraction

  2021cites this paper
• COMPARISON OF PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PRIMARY TUBES AND SAMPLE ALIQUOTS AFTER 4 HOURS DURATION

  2021cites this paper
• Antithrombotic therapies and their laboratory assessment

  2020cites this paper
• TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories

  2020cites this paper
• Determining the maximal storage time of centrifuged citrated samples for performing add-on routine coagulation tests.

  2020cites this paper
• Évaluation du citrate théophylline adénosine dipyridamole (CTAD) et du citrate comme anticoagulant dans la surveillance du traitement par héparine non fractionnée : validation d’une centrifugation différée pour le dosage de l’anti-Xa *

  2020cites this paper
• EFFECT OF STORAGE TIME ON PT, APTT AND FIBRINOGEN AT ROOM TEMPERATURE

  2020cites this paper
• International Council for Standardization in Haematology (ICSH) laboratory guidance for the evaluation of haemostasis analyser‐reagent test systems. Part 1: Instrument‐specific issues and commonly used coagulation screening tests

  2020cites this paper
• In Vitro Thrombogenicity Testing of Biomaterials

  2019cites this paper
• ASVCPGuidelines: Principles of Quality Assurance and Standards for Veterinary Clinical Pathology (version 3.0)

  2019cites this paper
• Prothrombin Time

  2019cites this paper
• ASVCP Guidelines: Principles of Quality Assurance and Standards for Veterinary Clinical Pathology (version 3.0): Developed by the American Society for Veterinary Clinical Pathology's (ASVCP) Quality Assurance and Laboratory Standards (QALS) Committee.

  2019cites this paper
• Monitoring unfractionated heparin therapy. 4 hour-stability of anti-Xa activity in unspun citrated tubes.

  2019cites this paper
• Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?

  2019cites this paper
• Effect of storage time on prothrombin time and activated partial thromboplastin time: study at a tertiary care center in Kashmir valley

  2018cites this paper
• Pre‐analytical stability of coagulation parameters in plasma stored at room temperature

  2018cites this paper
• The effects of transport temperature and time on routine and specialized coagulation assays

  2018cites this paper
• Advantages, disadvantages and optimization of one‐stage and chromogenic factor activity assays in haemophilia A and B

  2018cites this paper
• The effects of different centrifugation temperatures on blood coagulation parameters

  2018cites this paper
• Developing standards and test protocols for testing the hemocompatibility of biomaterials

  2018cites this paper
• Impact of different storage times at room temperature of unspun citrated blood samples on routine coagulation tests results. Results of a bicenter study and review of the literature

  2017cites this paper
• Low plasma FVII:C and activated FVII as predictive markers for overt disseminated intravascular coagulation

  2017cites this paper
• Is it acceptable to use coagulation plasma samples stored at room temperature and 4°C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D‐dimer testing?

  2017cites this paper
• Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist.

  2017cites this paper
• Critical pre-examination variables in the hemostasis laboratory and their quality indicators.

  2016cites this paper
• Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations

  2016cites this paper
• The Effect of Time and Temperature Variables on Some Routine Coagulation Tests among Subjects of African Descent in Sokoto, North Western Nigeria

  2016cites this paper
• Influence of the blood exposure time in dynamic hemocompatibility testing on coagulation and C5a activation

  2016cites this paper
• Preanalytical Variables in the Coagulation

  2016cites this paper
• Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample

  2015cites this paper
• Long-term stability of international standards for thromboplastin stored at -20°C, -70°C, and -150°C.

  2015cites this paper
• Determining the effect of freezing on coagulation testing: comparison of results between fresh and once frozen-thawed plasma

  2015cites this paper
• Effects of storage and thawing conditions on coagulation testing

  2015cites this paper
• Influence of Preanalytical Variables on Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen.

  2015cites this paper
• Transportation and Storage of Unprocessed or Processed Sodium Citrate Tubes for Plasma-Based Coagulation Assays

  2015cites this paper
• Effects of storage time and temperature on coagulation tests and factors in fresh plasma

  2014cites this paper
• Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.

  2014cites this paper
• [Stability of coagulation parameters: review of available data].

  2014cites this paper
• Influence of temperature and storage duration on measurement of activated partial thromboplastin time, D‐dimers, fibrinogen, prothrombin time and thrombin time, in citrate‐anticoagulated whole blood specimens

  2013cites this paper
• Best practices for veterinary toxicologic clinical pathology, with emphasis on the pharmaceutical and biotechnology industries.

  2013cites this paper
• [Importance of preanalytical step in hemostasis].

  2013cites this paper
• Are there sufficient standards for the in vitro hemocompatibility testing of biomaterials?

  2013cites this paper
• The Effect of Freezing Storage of Citrated Plasma on Prothrombin Time and Activated Partial Thromboplastin Time

  2013cites this paper
• Sample Integrity and Preanalytical Variables

  2013cites this paper
• Chapter 124 – Prothrombin Time

  2013cites this paper
• Coagulation assays and anticoagulant monitoring.

  2012cites this paper
• The effect of instrumentation and laboratory site on the accuracy of the APTT‐based heparin therapeutic range

  2012cites this paper
• Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

  2012cites this paper
• Pre-analytical Variables in Coagulation Testing Associated With Diagnostic Errors in Hemostasis

  2012cites this paper
• Challenges in the laboratory analyses of bleeding disorders.

  2012cites this paper
• Quality Standards for Sample Processing, Transportation, and Storage in Hemostasis Testing

  2012cites this paper
• ASVCP quality assurance guidelines: control of preanalytical and analytical factors for hematology for mammalian and nonmammalian species, hemostasis, and crossmatching in veterinary laboratories.

  2012cites this paper
• Sample Collection and Processing in Hemostasis

  2012cites this paper
• Optimization of the storage conditions for coagulation screening tests.

  2012cites this paper
• Changes of platelet function and blood coagulation during short-term storage of CPDA-1-stabilised ovine blood.

  2011cites this paper
• Optimization of the Storage Conditions for Coagulation Screening Tests

  2011cites this paper
• Étapes préanalytiques en hémostase

  2011cites this paper
• Influence of 8 and 24-h storage of whole blood at ambient temperature on prothrombin time, activated partial thromboplastin time, fibrinogen, thrombin time, antithrombin and D-dimer

  2011cites this paper
• Self-management of oral anticoagulation therapy--methodological and clinical aspects.

  2011cites this paper
• The importance of preanalytics for the coagulation laboratory

  2010cites this paper
• International Normalized Ratio (INR), coagulation factor activities and calibrated automated thrombin generation – influence of 24 h storage at ambient temperature

  2010cites this paper
• Coagulopathy in critically ill patients: part 2-soluble clotting factors and hemostatic testing.

  2010cites this paper
• Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?

  2010cites this paper
• Can Thromboelastography performed on kaolin‐activated citrated samples from critically ill patients provide stable and consistent parameters?

  2010cites this paper
• Results of a survey of hospital coagulation laboratories in the United States, 2001.

  2009influential citation
• Quality assurance for point‐of‐care testing of oral anticoagulation: a large‐scale evaluation of the Hemochron Junior Signature Microcoagulation System

  2009cites this paper
• Influence of temperature and time before centrifugation of specimens for routine coagulation testing

  2009cites this paper
• Coagulopathy in critically ill patients: part 1: platelet disorders.

  2009cites this paper
• Establishment of Reference Intervals for Kaolin-Activated Thromboelastography in Dogs Including an Assessment of the Effects of Sex and Anticoagulant Use

  2009cites this paper
• Interlaboratory agreement in the monitoring of unfractionated heparin using the anti‐factor Xa‐correlated activated partial thromboplastin time

  2009cites this paper
• Labormedizinische Aspekte des Thrombophilie-Screenings

  2008cites this paper
• Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature

  2008cites this paper
• [Screening for thrombophilia].

  2008cites this paper
• Preanalytical and Postanalytical Variables: The Leading Causes of Diagnostic Error in Hemostasis?

  2008cites this paper
• Sample collection and handling: getting accurate results.

  2007cites this paper
• How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.

  2007cites this paper
• Influence of centrifuge temperature on routine coagulation testing.

  2006cites this paper
• Quality and reliability of routine coagulation testing: can we trust that sample?

  2006influential citation
• CLOTTING PROFILES AND SELECTED HEMATOLOGY OF CAPTIVE SPEKE'S GAZELLES (GAZELLA SPEKEI)

  2006cites this paper
• [Self-management versus conventional management of oral anticoagulant therapy: a randomized controlled trial].

  2006cites this paper
• Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial.

  2006cites this paper
• Stability of activated partial thromboplastin time (APTT) test under different storage conditions

  2006influential citation
• Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy.

  2005cites this paper
• Non-frozen transports of whole blood samples do not cause relevant bias for global coagulation tests in clinical trials evaluating the drug safety.

  2005influential citation
• Challenges in Variation and Responsiveness of Unfractionated Heparin

  2004cites this paper
• Home prothrombin time monitoring: A literature analysis

  2004cites this paper
• Influence of Storage Time and Temperature on International Normalized Ratio (INR) Levels and Plasma Activities of Vitamin K Dependent Clotting Factors

  2004cites this paper
• Anticoagulation Monitoring

  2004cites this paper
• Preanalytical Variables in the Coagulation Laboratory

  2003cites this paper